miR-155 as a novel clinical target for hematological malignancies.
Witten, Lisa, and Frank J Slack. 2020. “MiR-155 As a Novel Clinical Target for Hematological Malignancies.”. Carcinogenesis 41 (1): 2-7.
Search
Search results
2993 results found
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer.
Gilles, Maud-Emmanuelle, Liangliang Hao, Kaelyn Brown, Jihoon Lim, Sangeeta N Bhatia, and Frank J Slack. 2019. “Tumor Penetrating Nanomedicine Targeting Both an OncomiR and an Oncogene in Pancreatic Cancer.”. Oncotarget 10 (51): 5349-58.
mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis.
Choe, Junho, Shuibin Lin, Wencai Zhang, Qi Liu, Longfei Wang, Julia Ramírez-Moya, Peng Du, et al. 2018. “MRNA Circularization by METTL3-EIF3h Enhances Translation and Promotes Oncogenesis.”. Nature 561 (7724): 556-60.
Nonfouling, Encoded Hydrogel Microparticles for Multiplex MicroRNA Profiling Directly from Formalin-Fixed, Paraffin-Embedded Tissue.
Nagarajan, Maxwell B, Augusto M Tentori, Wen Cai Zhang, Frank J Slack, and Patrick S Doyle. 2018. “Nonfouling, Encoded Hydrogel Microparticles for Multiplex MicroRNA Profiling Directly from Formalin-Fixed, Paraffin-Embedded Tissue.”. Analytical Chemistry 90 (17): 10279-85.
Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays.
Tentori, Augusto M, Maxwell B Nagarajan, Jae Jung Kim, Wen Cai Zhang, Frank J Slack, and Patrick S Doyle. 2018. “Quantitative and Multiplex MicroRNA Assays from Unprocessed Cells in Isolated Nanoliter Well Arrays.”. Lab on a Chip 18 (16): 2410-24.
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.
Adams, Brian D, Vikram B Wali, Christopher J Cheng, Sachi Inukai, Carmen J Booth, Seema Agarwal, David L Rimm, et al. 2016. “MiR-34a Silences C-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.”. Cancer Research 76 (4): 927-39.
The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.
Adams, Brian D, Christine Parsons, and Frank J Slack. 2016. “The Tumor-Suppressive and Potential Therapeutic Functions of MiR-34a in Epithelial Carcinomas.”. Expert Opinion on Therapeutic Targets 20 (6): 737-53.
MicroRNAs mediate dietary-restriction-induced longevity through PHA-4/FOXA and SKN-1/Nrf transcription factors.
Smith-Vikos, Thalyana, Alexandre de Lencastre, Sachi Inukai, Mariel Shlomchik, Brandon Holtrup, and Frank J Slack. 2014. “MicroRNAs Mediate Dietary-Restriction-Induced Longevity through PHA-4/FOXA and SKN-1/Nrf Transcription Factors.”. Current Biology : CB 24 (19): 2238-46.
Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.
Kim, Minlee, Xiaowei Chen, Lena J Chin, Trupti Paranjape, William C Speed, Kenneth K Kidd, Hongyu Zhao, Joanne B Weidhaas, and Frank J Slack. 2014. “Extensive Sequence Variation in the 3’ Untranslated Region of the KRAS Gene in Lung and Ovarian Cancer Cases.”. Cell Cycle (Georgetown, Tex.) 13 (6): 1030-40.
Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans.
Turner, Michael J, Alan L Jiao, and Frank J Slack. 2014. “Autoregulation of Lin-4 MicroRNA Transcription by RNA Activation (RNAa) in C. Elegans.”. Cell Cycle (Georgetown, Tex.) 13 (5): 772-81.